FDA bans sales of transvaginal mesh amid safety concerns

Malaysia News News

FDA bans sales of transvaginal mesh amid safety concerns
Malaysia Latest News,Malaysia Headlines
  • 📰 CNN
  • ⏱ Reading Time:
  • 36 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 95%

The FDA banned manufacturers of surgical mesh products from selling and distributing their products in the United States immediately. Each year thousands of women undergo transvaginal surgery mesh procedures.

Manufacturers of surgical mesh products must stop selling and distributing their products in the United States immediately, the US Food and Drug Administration ordered Tuesday.

The FDA said it"has determined that the manufacturers, Boston Scientific and Coloplast, have not demonstrated a reasonable assurance of safety and effectiveness for these devices."Each year, thousands of women undergo transvaginal surgery to repair pelvic organ prolapse, a condition where weakened muscles and ligaments cause the pelvic organs to drop lower in the pelvis, creating a bulge or prolapse in the vagina.

"Patients around the world have become unwitting test subjects for new medical technology," the consortium stated."Often following the trusted advice of their doctors, they have been injured, maimed and killed by poorly-tested implants."

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNN /  🏆 4. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA orders manufacturers to halt sales of surgical mesh used in certain pelvic operationsFDA orders manufacturers to halt sales of surgical mesh used in certain pelvic operationsThe agency ordered the two remaining manufacturers of surgical mesh used for certain pelvic operations to stop selling the products immediately, citing the lack of a “reasonable assurance” of safety and effectiveness.
Read more »

FDA pulls up Walmart, Kroger, others for selling tobacco to minorsFDA pulls up Walmart, Kroger, others for selling tobacco to minorsThe U.S. Food and Drug Administration (FDA) said on Friday it has sent letters t...
Read more »

We Asked The FDA About 8 Popular Food Safety MythsWe Asked The FDA About 8 Popular Food Safety MythsFrom drinking old milk to storing butter at room temperature to double-dipping chips.
Read more »

FDA orders Boston Scientific, Coloplast to stop selling surgical meshFDA orders Boston Scientific, Coloplast to stop selling surgical meshThe Food and Drug Administration orders Boston Scientific and Coloplast to stop selling surgical mesh used for some pelvic operations.
Read more »

The most common active ingredient in hand sanitizer is still under FDA investigationThe most common active ingredient in hand sanitizer is still under FDA investigationAfter reviewing the safety and effectiveness of hand sanitizers, the US Food and Drug Administration has ruled that dozens of active ingredients can't be used in the antiseptic rubs, but the agency still wants answers about the most common active ingredient.
Read more »

FDA threatens to fine Walmart, Kroger and convenience store chains for selling tobacco to minorsFDA threatens to fine Walmart, Kroger and convenience store chains for selling tobacco to minorsThe agency cited high rates of violations in nearly identical letters sent to retailers last week.
Read more »

FDA's stiff warning to health apps highlights opportunity for providersFDA's stiff warning to health apps highlights opportunity for providersFDA warned mobile health app and devices developers that claim to diagnose traumatic brain injuries, suggesting mHealth market is riddled with flaws.
Read more »

Johnson & Johnson wins U.S. FDA approval for bladder cancer drugJohnson & Johnson wins U.S. FDA approval for bladder cancer drugJohnson & Johnson's drug Balversa won U.S. approval as the first targeted t...
Read more »

FDA approves new osteoporosis drugFDA approves new osteoporosis drugThe US Food and Drug Administration on Tuesday approved the drug Evenity, or romosozumab, to treat osteoporosis in postmenopausal women at high risk of bone fractures.
Read more »

FDA orders transvaginal surgical mesh pulled from marketFDA orders transvaginal surgical mesh pulled from marketThe U.S. Food and Drug Administration on Tuesday ordered makers of transvaginal ...
Read more »



Render Time: 2025-02-27 21:54:46